• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用特定组成的疟疾肽载体蛋白偶联物的可变连接区免疫原性。

Variable linking region immunogenicity using malarial peptide carrier protein conjugates of defined composition.

作者信息

Jones G L, Spencer L, Mollard R, Saul A

机构信息

Queensland Institute of Medical Research, Herston, Australia.

出版信息

Immunol Lett. 1990 Dec;26(3):285-90. doi: 10.1016/0165-2478(90)90161-i.

DOI:10.1016/0165-2478(90)90161-i
PMID:2086458
Abstract

Thirty-five overlapping peptides from both conserved and variable parts of the N-terminal region of a malarial merozoite surface antigen (MSA2) were synthesised using solid phase chemistry. All peptides were synthesised with an added N-terminal cysteine and purified by reverse-phase HPLC to facilitate coupling to a carrier protein diphtheria toxoid (DT) using the hetero-bifunctional reagent maleimidocaproloxysuccinimide (MCS). Mice were immunised with these peptide-DT conjugates using Freund's complete adjuvant (FCA). The immune response of these mice was tested against peptide hapten, carrier protein (DT) and the linking region itself, using enzyme-linked immunoassay (ELISA). Although there was great variation in the immune response to each part of the immunogen construct, no significant correlation could be seen between each set of responses.

摘要

利用固相化学方法合成了疟原虫裂殖子表面抗原(MSA2)N端区域保守和可变部分的35个重叠肽段。所有肽段均在N端添加了半胱氨酸,并通过反相高效液相色谱法进行纯化,以便使用异双功能试剂马来酰亚胺己酰氧基琥珀酰亚胺(MCS)与载体蛋白白喉类毒素(DT)偶联。使用弗氏完全佐剂(FCA)对小鼠进行这些肽-DT偶联物免疫。使用酶联免疫吸附测定(ELISA)针对肽半抗原、载体蛋白(DT)和连接区域本身测试这些小鼠的免疫反应。尽管对免疫原构建体各部分的免疫反应存在很大差异,但每组反应之间未发现显著相关性。

相似文献

1
Variable linking region immunogenicity using malarial peptide carrier protein conjugates of defined composition.使用特定组成的疟疾肽载体蛋白偶联物的可变连接区免疫原性。
Immunol Lett. 1990 Dec;26(3):285-90. doi: 10.1016/0165-2478(90)90161-i.
2
Comparative immunogenicity of free and carrier-conjugated peptides derived from the constant regions of a polymorphic malarial surface antigen.
Immunol Lett. 1991 Mar;27(3):209-14. doi: 10.1016/0165-2478(91)90153-2.
3
Effect of context and adjuvant on the immunogenicity of recombinant proteins and peptide conjugates derived from the polymorphic malarial surface antigen MSA2.
Vaccine. 1996 Jan;14(1):77-84. doi: 10.1016/0264-410x(95)00149-u.
4
Synthetic peptide immunogens eliciting antibodies to Plasmodium falciparum sporozoite and merozoite surface antigens in H-2b and H-2k mice.在H-2b和H-2k小鼠中引发针对恶性疟原虫子孢子和裂殖子表面抗原抗体的合成肽免疫原。
J Immunol. 1990 Oct 15;145(8):2691-6.
5
The use of maleimidocaproyloxysuccinimide to prepare malarial peptide carrier immunogens. Immunogenicity of the linking region.
J Immunol Methods. 1989 Oct 24;123(2):211-6. doi: 10.1016/0022-1759(89)90224-x.
6
Immunological fine structure of the variable and constant regions of a polymorphic malarial surface antigen from Plasmodium falciparum.恶性疟原虫多态性疟疾表面抗原可变区和恒定区的免疫精细结构
Mol Biochem Parasitol. 1991 Sep;48(1):1-9. doi: 10.1016/0166-6851(91)90158-3.
7
Two immunogenic peptide conjugates derived from P. falciparum MSA2 give rise to antibodies that crossreact with a nonhomologous 195-kDa malarial protein.
Pept Res. 1993 Jul-Aug;6(4):191-4.
8
Immunogenicity and antigenic reactivity of a carrier-free synthetic peptide complex derived from a 70-kDa Plasmodium falciparum exoantigen.
Parasitol Res. 1993;79(6):501-7. doi: 10.1007/BF00931592.
9
Amino acid sequences recognized by T cells: studies on a merozoite surface antigen from the FCQ-27/PNG isolate of Plasmodium falciparum.T细胞识别的氨基酸序列:对恶性疟原虫FCQ - 27/巴布亚新几内亚分离株裂殖子表面抗原的研究
Immunol Lett. 1990 Aug;25(1-3):155-63. doi: 10.1016/0165-2478(90)90108-3.
10
Model multiple antigenic and homopolymeric peptides from non-repetitive sequences of malaria merozoite proteins elicit biologically irrelevant antibodies.
Biochim Biophys Acta. 1999 Jan 6;1453(1):115-25. doi: 10.1016/s0925-4439(98)00091-x.